These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24572582)

  • 41. Atypical antipsychotic use for adult outpatients in New Zealand's Auckland and Northland regions.
    Wheeler A
    N Z Med J; 2006 Jul; 119(1237):U2055. PubMed ID: 16862201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.
    Kinon BJ; Liu-Seifert H; Adams DH; Citrome L
    J Clin Psychopharmacol; 2006 Dec; 26(6):632-7. PubMed ID: 17110821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment changes among older patients with dementia treated with antipsychotics.
    Kim HM; Chiang C; Weintraub D; Schneider LS; Kales H
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1238-49. PubMed ID: 25759986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.
    Lambert BL; Cunningham FE; Miller DR; Dalack GW; Hur K
    Am J Epidemiol; 2006 Oct; 164(7):672-81. PubMed ID: 16943266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical antipsychotics for the treatment of disruptive behavior.
    Lohr WD; Honaker J
    Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
    [No Abstract]   [Full Text] [Related]  

  • 46. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van Marum RJ; Jansen PA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of special populations with the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():46-52. PubMed ID: 9766620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.
    Huybrechts KF; Gerhard T; Crystal S; Olfson M; Avorn J; Levin R; Lucas JA; Schneeweiss S
    BMJ; 2012 Feb; 344():e977. PubMed ID: 22362541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trends in antipsychotic use in dementia 1999-2007.
    Kales HC; Zivin K; Kim HM; Valenstein M; Chiang C; Ignacio RV; Ganoczy D; Cunningham F; Schneider LS; Blow FC
    Arch Gen Psychiatry; 2011 Feb; 68(2):190-7. PubMed ID: 21300946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parkinsonism and tardive antecollis in frontotemporal dementia--increased sensitivity to newer antipsychotics?
    Czarnecki K; Kumar N; Josephs KA
    Eur J Neurol; 2008 Feb; 15(2):199-201. PubMed ID: 18217890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival among elderly Italian patients with dementia treated with atypical antipsychotics: observational study.
    Nonino F; De Girolamo G; Gamberini L; Goldoni CA;
    Neurol Sci; 2006 Dec; 27(6):375-80. PubMed ID: 17205222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
    Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ
    Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis.
    Lin YT; Hwang TJ; Shan JC; Chiang HL; Sheu YH; Hwu HG
    J Formos Med Assoc; 2015 Feb; 114(2):147-53. PubMed ID: 25678176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atypical antipsychotics and risk of cerebrovascular accidents.
    Herrmann N; Mamdani M; Lanctôt KL
    Am J Psychiatry; 2004 Jun; 161(6):1113-5. PubMed ID: 15169702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004.
    Jano E; Johnson M; Chen H; Aparasu RR
    Curr Med Res Opin; 2008 Mar; 24(3):709-16. PubMed ID: 18226325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
    Erbe S; Gutwinski S; Bschor T
    Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract]   [Full Text] [Related]  

  • 59. [Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].
    Zuidema SU; van Iersel MB; Koopmans RT; Verhey FR; Olde Rikkert MG
    Ned Tijdschr Geneeskd; 2006 Jul; 150(28):1565-73. PubMed ID: 16886695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.